INanoBio, Inc.
Scottsdale, USA
|
INanoBio, Inc. develops high-accuracy early stage disease diagnostics using transformative nano-biotechnology platforms and machine learning. The company's aim is to develop preemptive disease diagnostics by extracting systems-scale information from complex disease biology, identifying and detecting disease specific molecular biomarker signatures at prodromal or pre-symptomatic stages.